Role of nafarelin in the management of endometriosis
RCT
OA: closed
CC0
⤵ 11 in-corpus citations
AI-generated summary
Nafarelin relieved endometriosis symptoms, reduced laparoscopic scores, and improved fertility in women, with side effects limited to hypoestrogenism.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A large, multicenter, double-blind clinical trial established that the gonadotropin releasing hormone analog nafarelin relieves clinical symptoms, decreases laparoscopic scores and improves fertility in women with endometriosis. Side effects were limited to those attributable to hypoestrogenism.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (11)
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis 2019
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- Ovulation suppression for endometriosis for women with subfertility 2007
- Management of the pain associated with endometriosis: an update of the painful problems 2006
- A randomized, parallel, comparative study of the efficacy and safety of nafarelin versus danazol in the treatment of endometriosis in Taiwan 2005
- Ovulation suppression for endometriosis 2003
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 1999
- Endometriosis. Diagnostic clues and new treatment options 1992
- Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions 1991
- Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions 1990
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:14:34.357477+00:00
License: CC0
· commercial use OK